National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Idera Pharmaceuticals

Therapeutic Approach

Injectables

Indication

Psoriasis

Mechanism

TLR 7,8, and 9 antagonist

Phase

Phase II

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.